Horizon Pharma PLC (NASDAQ:HZNP) is up close to 4% in pre-market trading after the company announced this morning that is adjusting its full year sales guidance for 2016. The company raised its net sales guidance from $1.025 billion to $1.050 billion for 2016 as it expects to close the acquisition of Crealta Holdings LLC sometime this week. Originally announced on December 11, Horizon will acquire Crealta for $510 million in cash. According to TipRanks’ statistics, out of the 10 analysts who have rated the company in the past 3 months, 8 gave a Buy rating, 1 gave a Sell rating, and 1 remains on the sidelines. The average 12-month price target for the stock is $35.70, marking a 97% upside from wehre shares last closed.
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) is down almost 7% in pre-market trading following yesterday’s announcement of investigations by Khang and Khang LLP, Levi and Korinksy LLP, and Block and Leviton LLP regarding the company reporting misleading financial information in 2015. In its annual report dated September 30, 2015, the company reported that it “had a material weakness in our internal control over financial reporting.” According to TipRanks’ statistics, 2 analysts have rated the company in the past 3 months with a Buy rating. The average 12-month price target for the stock is $138, marking a 145% upside from where shares last closed.
Lululemon Athletica inc. (NASDAQ:LULU) is up over 8% in pre-market trading to $59.20 after the company released updated fourth quarter guidance yesterday evening. The athletic retailer now expects to post net quarterly revenue between $690 million and $695 million, marking about a 15% year-over-year increase. The company also raised its diluted EPS estimates to the range of $0.78 – $0.80, up from the range of $0.75 – $0.78. In light of this news, Christian Buss of Credit Suisse reiterated a Buy rating on the company with a $60 price target. According to the 16 analysts polled by TipRanks in the last 3 months, 10 are bullish on LULU, 1 is bearish, and 5 remain neutral.
Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR) is down 4% in pre-market trading down to $3.56 following an announcement that the oil producer, owned and operated by Brazil, decreased its investments for the next 4 years by 25%. This investment figure is now $98.4 billion, the least the company has invested in years, though 80% of this investment will go towards exploration and production. Furthermore, U.S. oil prices hit a 12-year low yesterday.